Feb 9 (Reuters) - The U.S. Food and Drug Administration said a television advertisement for Novo Nordisk's weight-loss pill ...

Feb 9 (Reuters) - Regenxbio said on Monday the U.S. Food and Drug Administration had declined to approve its drug for Hunter ...

Feb 9 (Reuters) - Regenxbio said on Monday the U.S. Food and Drug Administration had declined to approve its gene therapy for ...

By Stine Jacobsen and Maggie Fick COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent ...

The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...

The FDA has outlined numerous concerns about the sale and use of unapproved GLP-1 drugs for weight loss.  “FDA is aware that ...

The agency will no longer crack down on manufacturers that use natural dyes in foods labeled ‘No artificial colors.’ Here’s ...

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...

THE Food and Drug Administration (FDA) recently launched its nationwide active monitoring of compliance to all establishments ...

In addition, FDA must be radically transparent about its outbreak investigations by releasing the name of the consumer-facing ...

No artificial colors” can now be used on food labels even if natural dyes are added. FDA will let companies use these claims ...

The recall was given a Class I designation by the FDA, which covers instances "in which there is a reasonable probability ...